The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
miR-124-3p attenuates MPP + -induced neuronal injury by targeting STAT3 in SH-SY5Y cells
Abstract
Ample evidence has demonstrated the involvement of microRNAs in Parkinson’s disease pathogenesis. miR-124-3p was reported to be able to improve neural functional recovery. However, the underlying mechanism of miR-124-3p in Parkinson’s disease progression was not well established. This study was designed to investigate the role of miR-124-3p in methyl phenyl pyridinium iodide (MPP) + -induced SH-SY5Y cells, an in vitro Parkinson’s disease model. It is observed that miR-124-3p expression was decreased, and STAT3 expression was increased in MPP + -induced SH-SY5Y cells. miR-124-3p overexpression attenuated MPP + -induced neuronal injury, displayed as increased cell viability and superoxide dismutase activities, as well as reduced cell apoptosis, Caspase-3 activity, lactate dehydrogenase activity, inflammatory factors TNF-α, and IL-1β levels and reactive oxygen species generation. Moreover, STAT3 was confirmed to be a miR-124-3p target. Restored STAT3 expression reversed miR-124-3p-induced neuroprotective effects against MPP + -mediated neuronal injury. These data demonstrated that miR-124-3p contributed to neuroprotective effects in MPP + -induced Parkinson’s disease cell model by targeting STAT3. Impact statement: PD affects millions of people in the world, causing uncontrolled tremors. MicroRNAs, a class of endogenous single-stranded non-coding transcript with approximately 22 nucleotides, could bind to the 3″ UTR of their targets. The functional action of miR-124-3p in PD was not fully elucidated. Our study found that ectopic expression miR-124-3p attenuated MPP + -induced injury in PD model in vitro by suppressing neurotoxicity, neuronal apoptosis, neuroinflammation, and oxidative stress. Moreover, we validated that miR-124-3p could bind to STAT3 mediating the neuroprotective effect of miR-124-3p. We believe this study will be interesting for readers of this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These miRNAs—miR-124-3p, miR-204-5p, miR-328-3p, and miR-181c-5p—regulate processes such as synaptic function [48–50], inflammation, and neuronal survival [51–56], which are similarly impacted by miR-129-5p [57–60] and miR-212-5p [61–66].”
From A role for astrocytic miR-129-5p in frontotemporal dementia (2025) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits
Xue, Y., Ouyang, K., Huang, J., Zhou, Y., Ouyang, H., Li, H., Wang, G., Wu, Q., Wei, C., Bi, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2012.11.045 · Cited by 562
An updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease
Saraiva, C., Paiva, J., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.005 · Cited by 169
Microglial activation in the pathogenesis of Huntington's disease
Yang, H.-M., Yang, S., Huang, S.-S., Tang, B.-S., & Guo, J.-F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00193 · Cited by 151
Research works printed but not linked: 31
- 10.1016/j.pnpbp.2016.04.011 · DOI
- 10.2174/1381612822666151112151653 · DOI
- 10.1111/jnc.13731 · DOI
- 10.1016/j.expneurol.2014.03.001 · DOI
- 10.1016/S0092-8674(04)00045-5 · DOI
- 10.1007/s13277-016-5436-9 · DOI
- 10.1007/s00018-015-2093-x · DOI · Paper page
- 10.1021/cn500149w · DOI
- 10.1523/JNEUROSCI.3900-15.2016 · DOI
- 10.1093/hmg/dds470 · DOI
- 10.1016/j.yexcr.2008.06.002 · DOI
- 10.1016/j.neuroscience.2014.04.039 · DOI · Paper page
- 10.1111/bpa.12267 · DOI · Paper page
- 10.1038/nprot.2008.73 · DOI · Paper page
- 10.1002/ijc.26120 · DOI
- 10.1016/j.neurobiolaging.2014.01.021 · DOI
- 10.1016/j.febslet.2014.12.014 · DOI
- 10.4161/rna.7.5.12262 · DOI
- 10.1111/j.1369-1600.2012.00470.x · DOI
- 10.2174/1566524016666151123114608 · DOI
- 10.1111/cas.12946 · DOI
- Sun Y, 2013, CNS Neurosci Ther, 19, 813, 10.1111/cns.12142 · DOI
- Kanagaraj N, 2004, J Org Chem, 69, 3794, 10.1021/jo035521u · DOI
- Gong X, 2016, Am J Transl Res, 8, 2127
- 10.1016/S1353-8020(11)70064-5 · DOI · Paper page
- 10.1038/onc.2016.271 · DOI
- 10.1016/j.arcmed.2016.07.001 · DOI
- 10.3233/JAD-150963 · DOI
- Li W, 1982, Immunology, 47, 503
- 10.1039/C6RA11759G · DOI
- 10.1016/j.neuro.2017.04.001 · DOI
Cited by
Sorted by citations
Song, Y., Li, Z., He, T., Qu, M., Jiang, L., Li, W., Shi, X., Pan, J., Zhang, L., Wang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30879 · Cited by 487
MicroRNA-124: A Key Player in Microglia-Mediated Inflammation in Neurological Diseases
Zhao, J., He, Z., & Wang, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.771898 · Cited by 66
miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
Xu, J., Zheng, Y., Wang, L., Liu, Y., Wang, X., Li, Y., & Chi, G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01091-6 · Cited by 55
A role for astrocytic miR-129-5p in frontotemporal dementia
Kaurani, L., Pradhan, R., Schröder, S., Burkhardt, S., Schuetz, A.-L., Krüger, D. M., Pena, T., Heutink, P., Sananbenesi, F., & Fischer, A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03338-y · Cited by 10
Metadata
- Authors
- Geng, L., Liu, W., & Chen, Y.
- Affiliations
- Department of Rehabilitation Medicine, Huaihe Hospital of Henan University, Kaifeng 475000, China
- Department of Neurology, Huaihe Hospital of Henan University, Kaifeng 475000, China
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2017-09-29
- Volume
- 242
- Issue
- 18
- Pages
- 1757-1764
- ISSN
- 1535-3702
- 1535-3699
- Cited by
- 63
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review